SCHEMBL4013403

SCHEMBL4013403

Cc1ccc2c(N3CCN(C(=O)OC(C)(C)C)CC3)nc(Cl)nc2c1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ GBA1 P04062 2/20 0.51
▸ TLR9 Q9NR96 4/20 0.50
▸ HRH4 Q9H3N8 1/20 0.46
▸ TLR7 Q9NYK1 2/20 0.45
▸ KIT P10721 1/20 0.45
▸ GPR119 Q8TDV5 2/20 0.44
▸ CNR1 P21554 1/20 0.43
▸ CNR2 P34972 1/20 0.43
▸ MAP4K4 O95819 1/20 0.43
▸ POLB P06746 1/20 0.42
▸ MEN1 O00255 3/20 0.42
▸ KMT2A Q03164 3/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ AKT1 P31749 1/20 0.42
▸ CKS1B P61024 1/20 0.42
▸ SKP1 P63208 1/20 0.42
▸ SKP2 Q13309 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2533854 0.85 GBA1 (0.67) GBA1TLR9TLR7KITGPR119
SCHEMBL4013931 0.85 HRH4 (0.50) GBA1HRH4MEN1KMT2ASMN1; SMN2
SCHEMBL16421555 0.83 TLR9 (0.47) GBA1TLR9HRH4TLR7KIT
SCHEMBL22220606 0.82 TLR9 (0.50) GBA1TLR9TLR7KITGPR119
SCHEMBL2918315 0.82 TLR9 (0.66) TLR9TLR7SMN1; SMN2
SCHEMBL30065068 0.82 TLR9 (0.50) GBA1TLR9TLR7KITGPR119
SCHEMBL16908185 0.82 GBA1 (0.60) GBA1TLR9KITGPR119MAP4K4
SCHEMBL4019288 0.81 CNR1 (0.46) CNR1CNR2CKS1BSKP1SKP2
SCHEMBL16636524 0.81 TLR9 (0.52) GBA1TLR9TLR7KITMEN1
SCHEMBL22028788 0.81 TLR9 (0.52) GBA1TLR9TLR7KITMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1784393-B1 QUINAZOLINES USEFUL AS MODULATORS OF ION CHANNELS VERTEX PHARMA (US) 2009-07-01 — — EP disclosed
EP-1784393-B1 QUINAZOLINES USEFUL AS MODULATORS OF ION CHANNELS VERTEX PHARMA (US) 2009-07-01 — — EP disclosed
EP-1784393-A1 QUINAZOLINES USEFUL AS MODULATORS OF ION CHANNELS Vertex Pharmaceuticals Incorporated (US) 2007-05-16 — — EP disclosed
WO-2006028904-A9 QUINAZOLINES USEFUL AS MODULATORS OF ION CHANNELS VERTEX PHARMA (US) 2006-06-22 — — WO disclosed
WO-2006028904-A1 QUINAZOLINES USEFUL AS MODULATORS OF ION CHANNELS VERTEX PHARMACEUTICALS INCORPORATED (US) 2006-03-16 — — WO disclosed
Send feedback